Warning: The NCBI web site requires JavaScript to function. more...
Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products.
Ludwig LB, Ambrus JL Jr, Krawczyk KA, Sharma S, Brooks S, Hsiao CB, Schwartz SA.
Retrovirology. 2006 Nov 8;3:80.
Related citations
A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF, Lombardi R, Nazari R, Joshi S.
Front Biosci. 2002 Feb 1;7:a15-28.
Detection, characterization and regulation of antisense transcripts in HIV-1.
Landry S, Halin M, Lefort S, Audet B, Vaquero C, Mesnard JM, Barbeau B.
Retrovirology. 2007 Oct 2;4:71.
Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK, Vandendriessche T, Chang HK, Ensoli B, Morgan RA.
Hum Gene Ther. 1994 Dec;5(12):1467-75.
RNA silencing and HIV: a hypothesis for the etiology of the severe combined immunodeficiency induced by the virus.
Ludwig LB.
Retrovirology. 2008 Sep 11;5:79.
Antisense RNA sequences targeting the 5' leader packaging signal region of human immunodeficiency virus type-1 inhibits viral replication at post-transcriptional stages of the life cycle.
Chadwick DR, Lever AM.
Gene Ther. 2000 Aug;7(16):1362-8.
Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes.
Krebs FC, Mehrens D, Pomeroy S, Goodenow MM, Wigdahl B.
J Biomed Sci. 1998;5(1):31-44.
Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
Liang C, Li X, Quan Y, Laughrea M, Kleiman L, Hiscott J, Wainberg MA.
J Mol Biol. 1997 Sep 19;272(2):167-77.
Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bel1 protein requires a specific DNA sequence.
Lee AH, Lee KJ, Kim S, Sung YC.
J Virol. 1992 May;66(5):3236-40.
Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.
Junker U, Böhnlein E, Veres G.
Gene Ther. 1995 Nov;2(9):639-46.
Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H, Callison D, Li P, Burrell C.
Virology. 1996 Jun 15;220(2):377-89.
Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.
Halin M, Douceron E, Clerc I, Journo C, Ko NL, Landry S, Murphy EL, Gessain A, Lemasson I, Mesnard JM, Barbeau B, Mahieux R.
Blood. 2009 Sep 17;114(12):2427-38. Epub 2009 Jul 14.
Human T-cell lymphotropic virus type 3 (HTLV-3)- and HTLV-4-derived antisense transcripts encode proteins with similar Tax-inhibiting functions but distinct subcellular localization.
Larocque É, Halin M, Landry S, Marriott SJ, Switzer WM, Barbeau B.
J Virol. 2011 Dec;85(23):12673-85. Epub 2011 Sep 14.
Enhancement or inhibition of HIV-1 replication by intracellular expression of sense or antisense RNA targeted at different intermediates of reverse transcription.
Peng H, Callison DE, Li P, Burrell CJ.
AIDS. 1997 Apr;11(5):587-95.
Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.
Logan AC, Haas DL, Kafri T, Kohn DB.
J Virol. 2004 Aug;78(16):8421-36.
Ku represses the HIV-1 transcription: identification of a putative Ku binding site homologous to the mouse mammary tumor virus NRE1 sequence in the HIV-1 long terminal repeat.
Jeanson L, Mouscadet JF.
J Biol Chem. 2002 Feb 15;277(7):4918-24. Epub 2001 Nov 30.
Inhibition of HIV-1 multiplication in a human CD4+ lymphocytic cell line expressing antisense and sense RNA molecules containing HIV-1 packaging signal and Rev response element(s).
Cohli H, Fan B, Joshi RL, Ramezani A, Li X, Joshi S.
Antisense Res Dev. 1994 Spring;4(1):19-26.
Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat.
Michael NL, Vahey MT, d'Arcy L, Ehrenberg PK, Mosca JD, Rappaport J, Redfield RR.
J Virol. 1994 Feb;68(2):979-87.
A basis for new approaches to the chemotherapy of AIDS: novel genes in HIV-1 potentially encode selenoproteins expressed by ribosomal frameshifting and termination suppression.
Taylor EW, Ramanathan CS, Jalluri RK, Nadimpalli RG.
J Med Chem. 1994 Aug 19;37(17):2637-54.
Polarized expression of the membrane ASP protein derived from HIV-1 antisense transcription in T cells.
Clerc I, Laverdure S, Torresilla C, Landry S, Borel S, Vargas A, Arpin-André C, Gay B, Briant L, Gross A, Barbeau B, Mesnard JM.
Retrovirology. 2011 Sep 19;8:74.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on